AZTR News
Archived Headlines
- Dermatology biotech Azitra cuts share offering by 38% ahead of $8 million IPO 06/05/23
- US IPO Week Ahead: Micro-cap biotech may price in an otherwise silent week 06/02/23
- US IPO Week Ahead: Post-Memorial Day IPO calendar is quiet for now 05/26/23
- US IPO Weekly Recap: Cummins spin-off and Canadian automation company raise a combined $521 million 05/26/23
- US IPO Week Ahead: Cummins spin-off Atmus and a small biotech aim to debut before Memorial Day 05/19/23
See more
US IPO Weekly Recap: Restaurant chain CAVA finishes up 73% after a successful IPO
Three companies priced this past week, two of which are eligible for inclusion in our IPO stats. They were joined by one SPAC. CAVA Group (CAVA) priced above the upwardly revised range, the first major IPO to do so since late 2021, raising...read more
Skin in the game: Dermatology biotech Azitra prices IPO at $5 midpoint
Azitra, a Phase 1-ready dermatology biotech developing engineered bacterial therapies, raised $8 million by offering 1.5 million shares at $5.00, within the range of $4.50 to $5.50. Azitra is focused on developing engineered proteins and live biotherapeutic...read more
US IPO Week Ahead: CAVA brings its fast-casual restaurant concept to the IPO market
Updated Monday, 6/12. Three companies are scheduled to price in the week ahead, two of which are eligible for inclusion in our IPO stats. The ...read more
US IPO Weekly Recap: No IPOs, but the pipeline gets a pickup with 3 new filers
There were no pricings this past week, as the sole scheduled deal delayed (AZTR). But the calendar still saw some activity, with restaurant chain CAVA Group (CAVA) launching its $260 million offering; it’s expected to price in the week...read more